Growth of Infants With Cow's Milk Allergy Fed an Amino Acid-based Formula Containing Two Human Milk Oligosaccharides

Exclusion Criteria

• •1. Previous treatment with AAF \> 72 hours
• •2. Known underlying medical condition that would impair growth (as per physician's assessment, e.g. unstable congenital heart disease, cystic fibrosis, metabolic disorder, chronic liver disease etc.)
• •3. Demonstrated chronic malabsorption which is not due to CMPA.
• •4. Other significant pre-natal and/or serious post-natal disease other than CMPA before enrolment (per investigator's medical decision).
• •5. Infants whose parents or caregivers who cannot give informed consent or who cannot be expected to comply with study procedures.
• •6. Treatment with systemic corticosteroids (oral or intravenous) for \>72 hours within 4 weeks before enrolment (topical corticosteroids allowed)
• •7. Infants taking probiotic preparations for \> 72 hour within 4 weeks before enrolment
• •8. Currently participating or having participated in another clinical trial since birth.